Latest / Decera Clinical Education Oncology Podcast
Congress to Clinic: Expert Takeaways on Emerging Data for MPNs
In this episode, listen to Dr Brady L. Stein share his clinical insights and takeaways on new data for myeloproliferative neoplasms (MPNs) presented at the 2024 ASCO Annual Meeting and the EHA 2024 Congress including:
Long-term survival adjusted for treatment crossover in patients with myelofibrosis (MF) treated with momelotinib vs danazol in the MOMENTUM trial
Efficacy of pacritinib in patients with MF who have both thrombocytopenia and anemia
Updated safety and efficacy data from the phase III MANIFEST-2 study of pelabresib in combination with ruxolitinib for JAK inhibitor–naive MF
Impact…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.